Practical Insights on the Identification and Management of Patients with Chronic Migraine

被引:2
作者
Blumenfeld, Andrew [1 ]
Dueland, Aud Nome [2 ,3 ]
Evers, Stefan [4 ]
Jenkins, Bronwyn [5 ]
Martelletti, Paolo [6 ]
Sommer, Katherine [7 ]
机构
[1] Headache Ctr Southern Calif, Neurol Ctr, Carlsbad, CA USA
[2] Sandvika Nevrosenter, Sandvika, Norway
[3] Oslo Univ Hosp, Dept Neurol, Rikshosp, Oslo, Norway
[4] Univ Munster, Munster, Germany
[5] Epping Clin, Sydney, NSW, Australia
[6] Sapienza Univ, Rome, Italy
[7] AbbVie Inc, 2525 Dupont Dr, Irvine, CA 92612 USA
关键词
Chronic migraine; Comorbidity; Diagnosis; Headache; Medical history; EPISODIC MIGRAINE; INTERNATIONAL BURDEN; HEALTH-CARE; OUTCOMES CAMEO; RESOURCE USE; DIAGNOSIS; HEADACHE; EPIDEMIOLOGY; PREVALENCE; DISABILITY;
D O I
10.1007/s40122-022-00387-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Chronic migraine (CM) is one of the most disabling diseases, and it is commonly misdiagnosed and mistreated. Despite the importance of a timely and accurate diagnosis for the effective management of CM, recent surveys have shown that only 20-25% of individuals with CM receive a correct diagnosis. The obvious consequences of misdiagnosed CM are prolongation of symptoms and their associated effects on disability and health-related quality of life. Additionally, mistreatment of CM can lead to acute medication overuse headache with escalation of headache and end organ damage. Ideally, a diagnosis of CM should be made in the primary care setting, based on a thorough medical history including detailed descriptions of headaches occurring earlier in life as well as current headaches, and the range of headaches (not just the worst headaches). In our experience, it is often equally informative to ask the patient about the number of headache-free days (HFDs) and no accompanying symptoms (i.e., crystal-clear days) to quantify headache days and accurately estimate headache frequency/impact. Headache frequency is important, as this count is one key means of diagnosing CM, which requires >= 15 headache days/month, noting that these do not need to be migraine days. A headache day is defined as more than 4 h a day of headache. Comorbidities are common in CM and may affect the treatment choice and increase disability. Every CM patient should be offered a preventive migraine treatment. In this commentary, we provide practical insights and tips for diagnosing CM and cover issues of medication overuse, patient communication, diagnostic testing, and when to make a referral. Our key message to physicians for a patient who comes to the clinic with frequent disabling headaches having features of migraine is to assume CM until proven otherwise.
引用
收藏
页码:447 / 457
页数:11
相关论文
共 47 条
  • [1] The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results
    Adams, Aubrey Manack
    Serrano, Daniel
    Buse, Dawn C.
    Reed, Michael L.
    Marske, Valerie
    Fanning, Kristina M.
    Lipton, Richard B.
    [J]. CEPHALALGIA, 2015, 35 (07) : 563 - 578
  • [2] Levels and determinants of knowledge about chronic migraine diagnosis and management among primary health-care physicians in ministry of health, Jeddah 2019
    Aljunaid, Mohammed Ahmed
    Jamal, Hussain Hassan
    Mubarak, Anas Ahmed
    Bardisi, Wedad
    [J]. JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2020, 9 (05) : 2324 - 2331
  • [3] Drug-Drug Interactions in Headache Medicine
    Ansari, Hossein
    Ziad, Sanaz
    [J]. HEADACHE, 2016, 56 (07): : 1241 - 1248
  • [4] The Diagnosis and Management of Chronic Migraine in Primary Care
    Becker, Werner J.
    [J]. HEADACHE, 2017, 57 (09): : 1471 - 1481
  • [5] Chronic migraine in the population - Burden, diagnosis, and satisfaction with treatment
    Bigal, Marcelo E.
    Serrano, Daniel
    Reed, Michael
    Lipton, Richard B.
    [J]. NEUROLOGY, 2008, 71 (08) : 559 - 566
  • [6] Concepts and mechanisms of migraine chronification
    Bigal, Marcelo E.
    Lipton, Richard B.
    [J]. HEADACHE, 2008, 48 (01): : 7 - 15
  • [7] Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS)
    Bloudek, L. M.
    Stokes, M.
    Buse, D. C.
    Wilcox, T. K.
    Lipton, R. B.
    Goadsby, P. J.
    Varon, S. F.
    Blumenfeld, A. M.
    Katsarava, Z.
    Pascual, J.
    Lanteri-Minet, M.
    Cortelli, P.
    Martelletti, P.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2012, 13 (05) : 361 - 378
  • [8] Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)
    Blumenfeld, A. M.
    Varon, S. F.
    Wilcox, T. K.
    Buse, D. C.
    Kawata, A. K.
    Manack, A.
    Goadsby, P. J.
    Lipton, R. B.
    [J]. CEPHALALGIA, 2011, 31 (03) : 301 - 315
  • [9] Clinician-Patient Dialogue About Preventive Chronic Migraine Treatment
    Blumenfeld, Andrew M.
    [J]. JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2020, 11
  • [10] Self-medication for migraine: A nationwide cross-sectional study in Italy
    Brusa, Paola
    Allais, Gianni
    Scarinzi, Cecilia
    Baratta, Francesca
    Parente, Marco
    Rolando, Sara
    Gnavi, Roberto
    Spadea, Teresa
    Costa, Giuseppe
    Benedetto, Chiara
    Mana, Massimo
    Giaccone, Mario
    Mandelli, Andrea
    Manzoni, Gian Camillo
    Bussone, Gennaro
    [J]. PLOS ONE, 2019, 14 (01):